Associated Medical Conditions for Histamine Issues,Mast Cell Issue, DAO Insufficiency

๐Ÿ“น Explaining this page and it's appropriate use.
The following is based on bacteria published studies. These are report on the averages of a group of patients; they do not apply to all patients and are not necessary predictive.

For some medical conditions there are hundreds of bacteria shifts reported, for others only a few. The Percentage is based on the least number. If there are matches 8 matches for a condition that has 10 known bacteria shifts, against a condition that has 50 bacteria shifts. It will be 8/10 or 80% and not 8/50= 16%. The count of possible bacteria is shown for reference.


Limited to conditions with 5 or more bacteria

Name Overlap Percent Prevalance in Population Matches Bacteria in From Bacteria in To
Schizophrenia 13.3 % 0.75% 4 93 30
Ankylosing spondylitis 20 % 7% 6 520 30
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 13.3 % 0.86% 4 134 30
Liver Cirrhosis 46.7 % 0.27% 14 678 30
Inflammatory Bowel Disease 16.7 % 1.3% 5 66 30
cystic fibrosis 14.3 % 0.03% 1 7 30
Atherosclerosis 53.3 % 50% 16 524 30
Small Intestinal Bacterial Overgrowth (SIBO) 25 % 52% 4 16 30
Generalized anxiety disorder 14.3 % 2.7% 2 14 30

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 ยงโ€ฏ1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.